REFERENCES
- McGowan JE Jr, Gerding DN. Does antibiotic restriction prevent resistance? New Horiz 1996; 4: 370–6.
- McGowan JE Jr. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis 1983; 5: 1033–48.
- Gaynes R. The impact of antimicrobial use on the emergence of antimicrobial-resistant bacteria in hospitals. Infect Dis Clin North Am 1997; 11: 757–65.
- Pallares R, Dick R, Wenzel RP, Adams JR, Nettleman MD. Trends in antimicrobial utilization at a tertiary teaching hospital during a 15-year period. Infect Control Hosp Epidemiol ; 14 1978; 1993: 376–82.
- Parret T, Schneider R, Rime B, Saghafi L, Pannatier A, Francioli P. Evaluation de l’utilisation des antibiotiques: une etude prospective dans un centre hospitalier universitaire. Schweiz Med Wochenschr 1993; 123: 403–13.
- Marschner JP, Thurmann P, Harder S, Rietbrock N. Drug utilization review on a surgical intensive care unit. Int J Clin Pharmacol Ther 1994; 32: 447–51.
- Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik SD. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 1998; 244: 379–86.
- Luna CM, Vujacich P, Niederman MS, Vay C, Gherardi C, Matera J, Jolly EC. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 1997; 111: 676–85.
- Bergogne-Berezin E. Current guidelines for the treatment and prevention of nosocomial infections. Drugs 1999; 58: 51–67.
- Coleman RW, Rodondi LC, Kaubisch S, Granzella NB, O’Hanley PD. Cost-effectiveness of prospective and continuous parenteral antibiotic control: experience at the Palo Alto Veterans Affairs Medical Center from to 1989. Am J Med ; 90 1987; 1991: 439–44.
- Dellinger EP, Gross PA, Barrett TL, Krause PJ, Martone WJ, McGowan JE Jr, et al. Quality standard for antimicrobial prophylaxis in surgical procedures. The Infectious Diseases Society of America. Infect Control Hosp Epidemiol 1994; 15: 182–8.
- Gross PA, Barrett TL, Dellinger EP, Krause PJ, Martone WJ, McGowan JE Jr, et al. Quality standard for the treatment of bacteremia. The Infectious Diseases Society of America. Infect Control Hosp Epidemiol 1994; 15: 189–92.
- Neu HC, Duma RJ, Jones RN, McGowan JE Jr, O’Brien TF, Sabath LD, et al. Therapeutic and epidemiologic recommendations to reduce the spread of type-I beta-lactamase resistance. Diagn Microbiol Infect Dis 1992; 15: 49–52S.
- Shlaes DM, Gerding DN, John JF Jr, Craig WA, Bornstein DL, Duncan RA, et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis 1997; 25: 584–99.
- Goldmann DA, Weinstein RA, Wenzel RP, Tablan OC, Duma RJ, Gaynes RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership. JAMA 1996; 275: 234–40.
- Dunagan WC, Woodward RS, Medoff G, Gray JL, Casabar ED, Smith MD, et al. Antimicrobial misuse in patients with positive blood cultures. Am J Med 1989; 87: 253–9.
- Till B, Williams L, Oliver SP, Pillans PI. A survey of inpatient antibiotic use in a teaching hospital. S Afr Med J 1991; 80: 7–10.
- Yu VL, Stoehr GP, Starling RC, Shogan JE. Empiric antibiotic selection by physicians: evaluation of reasoning strategies. Am J Med Sci 1991; 301: 165–72.
- Cooke D, Salter AJ, Phillips I. Antimicrobial misuse, antibiotic policies and information resources. J Antimicrob Chemother 1980; 6: 435–43.